These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 36884134)

  • 1. Overexpression of Parkin in the Neuronal Progenitor Cells from a Patient with Parkinson's Disease Shifts the Transcriptome Towards the Normal State.
    Lebedeva O; Poberezhniy D; Novosadova E; Gerasimova T; Novosadova L; Arsenyeva E; Stepanenko E; Shimchenko D; Volovikov E; Anufrieva K; Illarioshkin S; Lagarkova M; Grivennikov I; Tarantul V; Nenasheva V
    Mol Neurobiol; 2023 Jun; 60(6):3522-3533. PubMed ID: 36884134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of three induced pluripotent stem cell lines from a Parkinson's disease patient with mutant PARKIN (p. C253Y).
    Tariq M; Liu H; Ibañez DP; Li Y; Chen S; Jiang M; Fan W; Zhao P; Luo Z; Wang D; Kanwal S
    Stem Cell Res; 2020 May; 45():101822. PubMed ID: 32387897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.
    Aimé P; Sun X; Zareen N; Rao A; Berman Z; Volpicelli-Daley L; Bernd P; Crary JF; Levy OA; Greene LA
    J Neurosci; 2015 Jul; 35(30):10731-49. PubMed ID: 26224857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptome datasets of neural progenitors and neurons differentiated from induced pluripotent stem cells of healthy donors and Parkinson's disease patients with mutations in the
    Novosadova E; Anufrieva K; Kazantseva E; Arsenyeva E; Fedoseyeva V; Stepanenko E; Poberezhniy D; Illarioshkin S; Novosadova L; Gerasimova T; Nenasheva V; Grivennikov I; Lagarkova M; Tarantul V
    Data Brief; 2022 Apr; 41():107958. PubMed ID: 35242938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of bioactive metabolites in human iPSC-derived dopaminergic neurons with PARK2 mutation: Altered mitochondrial and energy metabolism.
    Okarmus J; Havelund JF; Ryding M; Schmidt SI; Bogetofte H; Heon-Roberts R; Wade-Martins R; Cowley SA; Ryan BJ; Færgeman NJ; Hyttel P; Meyer M
    Stem Cell Reports; 2021 Jun; 16(6):1510-1526. PubMed ID: 34048689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysosomal perturbations in human dopaminergic neurons derived from induced pluripotent stem cells with PARK2 mutation.
    Okarmus J; Bogetofte H; Schmidt SI; Ryding M; García-López S; Ryan BJ; Martínez-Serrano A; Hyttel P; Meyer M
    Sci Rep; 2020 Jun; 10(1):10278. PubMed ID: 32581291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of hiPSCs (JUCGRMi003-A) from a patient with Parkinson's disease with PARK2 mutation.
    Ishikawa KI; Okuzumi A; Yoshino H; Hattori N; Akamatsu W
    Stem Cell Res; 2024 Apr; 76():103323. PubMed ID: 38309147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and mtDNA Levels in a Mouse Model of Parkinson's Disease.
    Pinto M; Nissanka N; Moraes CT
    J Neurosci; 2018 Jan; 38(4):1042-1053. PubMed ID: 29222404
    [No Abstract]   [Full Text] [Related]  

  • 10. The ubiquitin E3 ligase Parkin regulates neuronal Ca
    Grimaldo L; Sandoval A; Duran P; Gómez Flores-Ramos L; Felix R
    J Neurophysiol; 2022 Dec; 128(6):1555-1564. PubMed ID: 36350063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
    Yasuda T; Mochizuki H
    Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endoplasmic reticulum-mitochondria interface is perturbed in PARK2 knockout mice and patients with PARK2 mutations.
    Gautier CA; Erpapazoglou Z; Mouton-Liger F; Muriel MP; Cormier F; Bigou S; Duffaure S; Girard M; Foret B; Iannielli A; Broccoli V; Dalle C; Bohl D; Michel PP; Corvol JC; Brice A; Corti O
    Hum Mol Genet; 2016 Jul; 25(14):2972-2984. PubMed ID: 27206984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous Parkin Preserves Dopaminergic Substantia Nigral Neurons following Mitochondrial DNA Mutagenic Stress.
    Pickrell AM; Huang CH; Kennedy SR; Ordureau A; Sideris DP; Hoekstra JG; Harper JW; Youle RJ
    Neuron; 2015 Jul; 87(2):371-81. PubMed ID: 26182419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation mechanisms of the E3 ubiquitin ligase parkin.
    Panicker N; Dawson VL; Dawson TM
    Biochem J; 2017 Aug; 474(18):3075-3086. PubMed ID: 28860335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-specific overexpression of COMT in dopaminergic neurons of Parkinson's disease.
    Kuzumaki N; Suda Y; Iwasawa C; Narita M; Sone T; Watanabe M; Maekawa A; Matsumoto T; Akamatsu W; Igarashi K; Tamura H; Takeshima H; Tawfik VL; Ushijima T; Hattori N; Okano H; Narita M
    Brain; 2019 Jun; 142(6):1675-1689. PubMed ID: 31135049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.
    Hennis MR; Marvin MA; Taylor CM; Goldberg MS
    Neurobiol Dis; 2014 Feb; 62():113-23. PubMed ID: 24075852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SLP-2 interacts with Parkin in mitochondria and prevents mitochondrial dysfunction in Parkin-deficient human iPSC-derived neurons and Drosophila.
    Zanon A; Kalvakuri S; Rakovic A; Foco L; Guida M; Schwienbacher C; Serafin A; Rudolph F; Trilck M; Grünewald A; Stanslowsky N; Wegner F; Giorgio V; Lavdas AA; Bodmer R; Pramstaller PP; Klein C; Hicks AA; Pichler I; Seibler P
    Hum Mol Genet; 2017 Jul; 26(13):2412-2425. PubMed ID: 28379402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling correlative roles of dopamine transporter (DAT) and Parkin in Parkinson's disease (PD) - A road to discovery?
    Jayaramayya K; Iyer M; Venkatesan D; Balasubramanian V; Narayanasamy A; Subramaniam MD; Cho SG; Vellingiri B
    Brain Res Bull; 2020 Apr; 157():169-179. PubMed ID: 32035946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of the parkin substrate, FAF1, plays a key role in the dopaminergic neurodegeneration.
    Sul JW; Park MY; Shin J; Kim YR; Yoo SE; Kong YY; Kwon KS; Lee YH; Kim E
    Hum Mol Genet; 2013 Apr; 22(8):1558-73. PubMed ID: 23307929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkin deficiency exacerbate ethanol-induced dopaminergic neurodegeneration by P38 pathway dependent inhibition of autophagy and mitochondrial function.
    Hwang CJ; Kim YE; Son DJ; Park MH; Choi DY; Park PH; Hellström M; Han SB; Oh KW; Park EK; Hong JT
    Redox Biol; 2017 Apr; 11():456-468. PubMed ID: 28086194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.